Renalytix Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020
Market Capitalization	45	109	89	1,112	-
Market Cap Growth	-	23.22%	-92.03%	-	-
Enterprise Value	48	97	60	1,046	-14
PE Ratio	-0.45	-2.39	-1.96	-32.01	-
PS Ratio	18.58	32.08	29.82	745.60	-
PB Ratio	-2.39	15.67	2.89	15.56	-
P/FCF Ratio	-0.53	-3.20	-1.90	-37.15	-
P/OCF Ratio	-0.53	-3.20	-1.93	-39.15	-
EV/Sales Ratio	19.77	28.38	20.04	701.87	-
EV/EBITDA Ratio	-0.53	-2.15	-1.33	-30.38	1.43
EV/EBIT Ratio	-0.52	-2.12	-1.32	-30.14	1.42
EV/FCF Ratio	-0.60	-2.83	-1.28	-34.97	1.30
Debt / Equity Ratio	-1.07	1.74	0.40	-	0.02
Debt / EBITDA Ratio	-0.21	-0.27	-0.28	-	-0.03
Debt / FCF Ratio	-0.23	-0.36	-0.26	-	-0.02
Quick Ratio	0.50	1.58	3.59	9.32	4.34
Current Ratio	0.59	1.67	3.80	9.46	4.51
Asset Turnover	0.10	0.10	0.06	0.02	0
Return on Equity (ROE)	-1071.90%	-345.60%	-109.20%	-42.40%	-80.50%
Return on Assets (ROA)	-165.30%	-130.50%	-83.80%	-40.10%	-64.40%
Return on Capital (ROIC)	-7269.13%	-221.21%	-123.83%	-44.66%	-63.80%
Earnings Yield	-93.44%	-41.78%	-51.11%	-3.12%	-
FCF Yield	-80.73%	-31.23%	-52.59%	-2.69%	-
Buyback Yield / Dilution	-29.88%	-11.34%	-3.29%	-21.00%	-38.81%
Total Shareholder Return	-29.88%	-11.34%	-3.29%	-21.00%	-38.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).